UBS AM’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67M | Buy |
404,736
+125,689
| +45% | +$1.76M | ﹤0.01% | 1653 |
|
|
2025
Q1 | $4.36M | Sell |
279,047
-1,053
| -0.4% | -$16.5K | ﹤0.01% | 1640 |
|
|
2024
Q4 | $3.9M | Buy |
280,100
+3,409
| +1% | +$47.5K | ﹤0.01% | 1732 |
|
|
2024
Q3 | $2.57M | Buy |
276,691
+2,912
| +1% | +$27.1K | ﹤0.01% | 1918 |
|
|
2024
Q2 | $2.55M | Buy |
+273,779
| New | +$2.55M | ﹤0.01% | 1867 |
|
|
2023
Q4 | – | Sell |
-81,080
| Closed | -$431K | – | 2545 |
|
|
2023
Q3 | $431K | Buy |
81,080
+21,465
| +36% | +$114K | ﹤0.01% | 2349 |
|
|
2023
Q2 | $656K | Hold |
59,615
| – | – | ﹤0.01% | 2214 |
|
|
2023
Q1 | $656K | Buy |
59,615
+25,899
| +77% | +$285K | ﹤0.01% | 2214 |
|
|
2022
Q4 | $499K | Buy |
33,716
+14,616
| +77% | +$216K | ﹤0.01% | 2177 |
|
|
2022
Q3 | $365K | Sell |
19,100
-10,872
| -36% | -$208K | ﹤0.01% | 2451 |
|
|
2022
Q2 | $639K | Hold |
29,972
| – | – | ﹤0.01% | 2194 |
|
|
2022
Q1 | $577K | Hold |
29,972
| – | – | ﹤0.01% | 2414 |
|
|
2021
Q4 | $622K | Hold |
29,972
| – | – | ﹤0.01% | 2458 |
|
|
2021
Q3 | $716K | Hold |
29,972
| – | – | ﹤0.01% | 2331 |
|
|
2021
Q2 | $818K | Buy |
29,972
+8,772
| +41% | +$239K | ﹤0.01% | 2323 |
|
|
2021
Q1 | $613K | Buy |
+21,200
| New | +$613K | ﹤0.01% | 2317 |
|